NNNN · Anbio Biotechnology
Market Cap
$163.71M
Shares
43.89M
Volume · Oct 21
113.95K
Avg daily vol (3M)
150.79K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.72
Open$3.64
Day$3.53–4.00
52W close$3.13–41.11
Avg vol 30d144K
Short int54K · 0.1% float · 1.0d
Short vol49%
DataFeb 2025–Oct 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+5.6%
Year over year
Operating margin
66.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.3%
Year over year · more shares
Price change (1Y)
-87.6%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−80%
below
Price vs 50-day avg
−40%
below
RSI (14)
31
neutral
MACD trend
Negative
52-week position
2%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−39%
trailing
6-month return
−87%
trailing
YTD return
−88%
this year
Relative strength
−95%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $18 — 200d above 50d
Institutional flow
Accumulating
+50% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.12% of float · ▲ +4.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
12 holders — near 1-yr high, broad support
Squeeze score
24
low risk · 0–100
Fundamentals
Revenue growth
+6%
Y/Y
Gross margin
87%
expanding
EPS growth
+163%
Y/Y
Balance sheet
$7.8M
net cash
Quant / Vol
risk profile
Volatility
140%
annualized · 1-yr
Max drawdown
−92%
past year
ATR
16.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−80%
Bearish
Price vs 50-day avg
−40%
Bearish
RSI (14)
31
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $6 › 200d $18 — 200d above 50d
Institutional flow
Accumulating
+50% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.12% of float · ▲ +4.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
12 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $3
Now $4 · 2%
Range high $41
vs 200-day avg -80%
vs 50-day avg -40%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NNNN
this stock
Anbio Biotechnology
|
$163.71M | -87.6% | +5.6% | — | 0.1% |
|
ISRG
Intuitive Surgical Inc
|
$154.74B | -24.4% | +20.5% | 53.1 | 2.1% |
|
BDX
Becton Dickinson & Co
|
$52.93B | — | +8.2% | — | 3.6% |
|
MDLN
Medline Inc.
|
$46.62B | -15.9% | +11.5% | — | 4.0% |
|
RMD
Resmed Inc
|
$35.41B | +2.2% | +13.4% | 23.5 | 8.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NNNN | +4.2% | -38.6% | -87.0% | -41.0% | -87.6% |
| SPY | +0.5% | +0.7% | +7.6% | +1.4% | +13.4% |
| vs SPY | +3.8% | -39.3% | -94.5% | -42.3% | -101.0% |